Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Jun. 30, 2022
CURRENT ASSETS
Cash and cash equivalents	$ 69	$ 324,494
Accounts receivable	5,000	5,000
Accrued interest receivable	16,343	7,521
Loan receivable, other	17,533	18,380
Total current assets	38,945	355,395
Property and equipment, less accumulated depreciation of $16,015 and $13,419	20,348	22,944
Notes receivable	350,000	350,000
Total other assets	370,348	372,944
TOTAL ASSETS	409,293	728,339
CURRENT LIABILITIES
Accounts payable	33,152	15,562
Accrued interest	59,515	47,839
Accrued directors compensation	18,074
Notes payable-third parties	300,000	387,500
Loan payable, related party	2,250	2,250
Debt discounts		(49,863)
Derivative liability	568,684	1,272,799
Total current liabilities	981,675	1,676,087
TOTAL LIABILITIES	981,675	1,676,087
STOCKHOLDERS’ DEFICIENCY
Common stock; 14,991,000,000 shares authorized, $.0001 par value, as of December 31, 2022 and June 30, 2022, there are 14,488,440,097 and 13,785,662,319 shares outstanding, respectively	1,448,844	1,378,566
Additional paid- in capital Class A common stock	162,913,727	162,732,907
Additional paid- in capital preferred stock	1,385,113	1,385,113
Accumulated deficit	(166,320,069)	(166,444,337)
Total stockholders’ deficiency	(572,382)	(947,748)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY	409,293	728,339
Series K Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value
Series L Preferred Stock [Member]
STOCKHOLDERS’ DEFICIENCY
Preferred stock value	$ 3	$ 3